[{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Dr. Scott  Koenig M.D., Ph.D.", "age": 72, "title": "President, CEO & Director", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 1090301, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Karrels", "age": 57, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 663431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen L. Eck M.D., Ph.D.", "age": 69, "title": "Senior VP of Clinical Development & Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 735308, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 57, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 70, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 53, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Smith", "age": 56, "title": "VP, Controller & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 7, "overallRisk": 6, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.55, "open": 1.5, "dayLow": 1.48, "dayHigh": 1.595, "regularMarketPreviousClose": 1.55, "regularMarketOpen": 1.5, "regularMarketDayLow": 1.48, "regularMarketDayHigh": 1.595, "payoutRatio": 0.0, "beta": 1.632, "forwardPE": -0.63070536, "volume": 923638, "regularMarketVolume": 923106, "averageVolume": 1155874, "averageVolume10days": 3555550, "averageDailyVolume10Day": 3555550, "bid": 1.49, "ask": 1.55, "bidSize": 1, "askSize": 3, "marketCap": 95897256, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 5.77, "priceToSalesTrailing12Months": 0.62250733, "fiftyDayAverage": 1.4858, "twoHundredDayAverage": 2.721975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -18885000, "profitMargins": -0.3623, "floatShares": 51666558, "sharesOutstanding": 63090300, "sharesShort": 6121094, "sharesShortPriorMonth": 5678775, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.096999995, "heldPercentInsiders": 0.03014, "heldPercentInstitutions": 0.89655, "shortRatio": 15.11, "shortPercentOfFloat": 0.119399995, "impliedSharesOutstanding": 63090300, "bookValue": 1.254, "priceToBook": 1.2121212, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -55812000, "trailingEps": -0.88, "forwardEps": -2.41, "enterpriseToRevenue": -0.123, "enterpriseToEbitda": 0.205, "52WeekChange": -0.64568764, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 1.52, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.2, "targetMedianPrice": 3.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 154140992, "totalCashPerShare": 2.443, "ebitda": -91982000, "totalDebt": 37466000, "quickRatio": 2.97, "currentRatio": 3.284, "totalRevenue": 154050000, "debtToEquity": 47.354, "revenuePerShare": 2.453, "returnOnAssets": -0.26291, "returnOnEquity": -0.60248, "grossProfits": -38981000, "freeCashflow": -40451124, "operatingCashflow": -69620000, "revenueGrowth": 0.449, "grossMargins": -0.25304002, "ebitdaMargins": -0.59709, "operatingMargins": -3.23105, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "MacroGenics, Inc.", "longName": "MacroGenics, Inc.", "averageDailyVolume3Month": 1155874, "fiftyTwoWeekLowChange": 0.53, "fiftyTwoWeekLowChangePercent": 0.5353535, "fiftyTwoWeekRange": "0.99 - 5.77", "fiftyTwoWeekHighChange": -4.25, "fiftyTwoWeekHighChangePercent": -0.73656845, "fiftyTwoWeekChangePercent": -64.56876, "earningsTimestamp": 1747166460, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.88, "epsForward": -2.41, "epsCurrentYear": -0.63, "priceEpsCurrentYear": -2.4126985, "fiftyDayAverageChange": 0.034199953, "fiftyDayAverageChangePercent": 0.02301787, "twoHundredDayAverageChange": -1.2019751, "twoHundredDayAverageChangePercent": -0.44158196, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "postMarketChangePercent": -1.3092082, "postMarketPrice": 1.5001, "postMarketChange": -0.019899964, "regularMarketChange": -0.03, "regularMarketDayRange": "1.48 - 1.595", "fullExchangeName": "NasdaqGS", "corporateActions": [], "postMarketTime": 1749858891, "regularMarketTime": 1749844801, "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.93548, "regularMarketPrice": 1.52, "displayName": "MacroGenics", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]